Preliminary evaluation of deep learning for first-line diagnostic prediction of tumor mutational status
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Preliminary evaluation of deep learning for first-line diagnostic prediction of tumor mutational status ; volume:13 ; number:1 ; day:28 ; month:4 ; year:2023 ; pages:1-11 ; date:12.2023
Scientific reports ; 13, Heft 1 (28.4.2023), 1-11, 12.2023
- Urheber
-
Morel, Louis-Oscar
Derangère, Valentin
Arnould, Laurent
Ladoire, Sylvain
Vinçon, Nathan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-34016-y
- URN
-
urn:nbn:de:101:1-2023090411555753327774
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Morel, Louis-Oscar
- Derangère, Valentin
- Arnould, Laurent
- Ladoire, Sylvain
- Vinçon, Nathan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
Evolution of RAS mutational status in liquid biopsies during first-line chemotherapy for metastatic colorectal cancer
AIH Therapy: Beyond First-Line
A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies
Tongue as a first-line immune organ?
Humoral First-Line Mucosal Innate Defence in vivo
Challenges to replace ACT as first-line drug
Medication beliefs in first-line and second-line treated multiple sclerosis patients
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Human scent as a first-line defense against disease
Implementing Human Resource Management successfully: A first-line management challenge
First-Line Immunotherapy in Advanced Non-Small-Cell Lung Cancer
Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
Evolution of RAS mutational status in liquid biopsies during first-line chemotherapy for metastatic colorectal cancer
AIH Therapy: Beyond First-Line
A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies
Tongue as a first-line immune organ?
Humoral First-Line Mucosal Innate Defence in vivo
Challenges to replace ACT as first-line drug
Medication beliefs in first-line and second-line treated multiple sclerosis patients
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Human scent as a first-line defense against disease
Implementing Human Resource Management successfully: A first-line management challenge
First-Line Immunotherapy in Advanced Non-Small-Cell Lung Cancer
Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
Evolution of RAS mutational status in liquid biopsies during first-line chemotherapy for metastatic colorectal cancer
AIH Therapy: Beyond First-Line
A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies
Tongue as a first-line immune organ?
Humoral First-Line Mucosal Innate Defence in vivo
Challenges to replace ACT as first-line drug
Medication beliefs in first-line and second-line treated multiple sclerosis patients
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Human scent as a first-line defense against disease
Implementing Human Resource Management successfully: A first-line management challenge